Skip to Main Content

++

I. Intensive care

++

  1. Bronchopulmonary dysplasia (BPD)

    1. Definition: Chronic pulmonary disease characterized by need for supplemental oxygen for at least 28 days after birth and/or oxygen requirement at 36 weeks' postmenstrual age (PMA).

    2. Incidence: Approximately 30% for infants with birthweight <1000 g, 20% for infants born at <1500 g, and estimated gestational age <30 weeks. May be as high as 70% in the tiniest infants.

    3. Pathophysiology

      1. Old: primarily seen prior to the advent of surfactant replacement therapy; characterized by airway injury, inflammation, parenchymal fibrosis

      2. New: found in extremely low birthweight infants; an arrest in lung development with fewer and larger alveoli, decreased pulmonary microvascular development

    4. Risk factors

      1. Prematurity: Incidence increases with decreasing estimated gestational age (EGA) and birthweight.

      2. Chorioamnionitis/sepsis: Increased incidence in infants born with exposure to infection/inflammation.

      3. Prolonged mechanical ventilation: Injury primarily due to tidal volumes that overdistend airways and cause volutrauma/barotrauma.

      4. Patent ductus arteriosus (PDA): Due to pulmonary overcirculation.

      5. Oxygen: Toxicity due to hyperoxia and inadequate levels of antioxidants that leads to cellular damage.

      6. Genetic contribution: Genetic factors largely contribute to the development of BPD in preterm infants.

      7. Poor nutrition: Growth and optimal nutritional status contribute to healing and maturation of lung tissue.

    5. Clinical presentation

      1. Signs and symptoms

        • Respiratory insufficiency: Need for supplemental oxygen or distending pressure via continuous positive airway pressure (CPAP) or high flow nasal cannula (HFNC).

        • Pulmonary edema: Increased microvascular pressure causes fluid filtration into the perivascular interstitium.

        • Tachypnea.

        • Increased work of breathing.

      2. Condition variability

        • Mild BPD: management with medications, on room air

        • Moderate BPD: oxygen requirement up to 30%

        • Severe BPD: oxygen requirement >30%, ventilator/CPAP dependent, or pulmonary hypertension

    6. Diagnosis

      1. Oxygen dependence for at least 28 days after birth.

      2. Oxygen requirement continuing at 36 weeks' PMA for infants born at <32 weeks' EGA or at 56 days of life for infants born >32 weeks.

      3. Chest radiographic findings may include haziness due to pulmonary edema and/or atelectasis and low lung volumes. Findings in severe BPD include hyperinflation, cystic areas, and patchy atelectasis.

      4. Physical examination: Tachypnea is the major finding; may be accompanied by retractions, rales, or wheezing.

    7. Management

      1. Medical

        1. Respiratory Support

          • Mechanical ventilation: Severe BPD.

          • Oxygen: Saturations >94% may be necessary to prevent/treat pulmonary hypertension in the infant with established BPD and to promote growth.

          • Nitric oxide: Acts to reduce pulmonary vascular tone; may prevent BPD in some infants or treat pulmonary hypertension. Used in the acute setting.

        2. Medications

          • Diuretics (for dosing, see the Convalescent Care section later): Treats associated pulmonary edema.

          • Corticosteroids: Due to associated negative impacts on long-term neurodevelopmental outcomes and growth, systemic steroids should be reserved for severe cases of BPD. Dexamethasone course is most common.

          • Inhaled medications (for dosing, see the Convalescent Care section later)

            • Bronchodilators: β-Agonists (albuterol or Xopenex) or anticholinergics (ipratropium bromide) can be used to treat airway hyperactivity/bronchospasm.

            • Steroids (budesonide/Pulmicort) reduce airway inflammation and may be used over a prolonged period (1 to 4 weeks) to achieve reduced inflammation similar to systemic corticosteroids without the adverse effects.

          • Vitamin A: Shown to reduce BPD in ELBW infants.

      2. Surgical

        • Bronchoscopy: Tracheobronchomalacia may complicate BPD due to airway collapse during expiration. Rigid bronchoscopy can be used to assess this as a contributing factor in moderate to severe disease.

        • Tracheostomy: May be ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessPediatrics Full Site: One-Year Subscription

Connect to the full suite of AccessPediatrics content and resources including 20+ textbooks such as Rudolph’s Pediatrics and The Pediatric Practice series, high-quality procedural videos, images, and animations, interactive board review, an integrated pediatric drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessPediatrics

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.